These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2177029)

  • 1. [Glaucoma in central hypothalamic-hypophyseal Cushing syndrome].
    Huschle OK; Jonas JB; Koniszewski G; Buchfelder M; Fahlbusch R
    Fortschr Ophthalmol; 1990; 87(5):453-6. PubMed ID: 2177029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure in patients with Cushing's disease.
    Jonas JB; Huschle O; Koniszewski G; Buchfelder M; Fahlbusch R
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(5):407-9. PubMed ID: 2227481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB; Stroux A; Martus P; Budde W
    J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Pan CY; Luo GC; Li JY; Wang YZ; Lu SZ; Ma SQ; Guo AY
    Chin Med J (Engl); 1989 Nov; 102(11):890-4. PubMed ID: 2561555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranking of optic disc variables for detection of glaucomatous optic nerve damage.
    Jonas JB; Bergua A; Schmitz-Valckenberg P; Papastathopoulos KI; Budde WM
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1764-73. PubMed ID: 10845597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
    Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
    Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The retinal nerve fiber layer in normal and glaucoma eyes].
    Jonas JB; Schiro D; Naumann GO
    Ophthalmologe; 1993 Dec; 90(6):603-12. PubMed ID: 8124022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cortisol in glaucoma.
    Ray S; Mehra KS; Misra S; Singh R
    Ann Ophthalmol; 1977 Sep; 9(9):1151-4. PubMed ID: 561563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cortisol differences between normal and glaucomatous patients: before and after dexamethasone suppresion.
    Schwartz B; Levene RZ
    Arch Ophthalmol; 1972 Apr; 87(4):369-77. PubMed ID: 5018239
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences of adrenal stress control mechanisms in subjects with glaucoma and normal subjects. Effect of vasopressin and pyrogen.
    Schwartz B; Golden MA; Wiznia RA; Miller SA
    Arch Ophthalmol; 1981 Oct; 99(10):1770-7. PubMed ID: 7295125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hypothalamo-hypophyseal-adrenal gland system and steroid glaucoma].
    Schwartz B
    Klin Monbl Augenheilkd; 1972 Sep; 161(3):280-7. PubMed ID: 4567239
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of Cushing disease. An evaluation of endocrinology test for three years following hypothalamic-pituitary irradiation and reserpin administration (author's transl)].
    Yamada Y; Nohara Y; Hattori T; Fujieda K; Endo M
    Horumon To Rinsho; 1979 Sep; 27(9):1019-24. PubMed ID: 230921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.